Michael Lever

5.7k total citations · 1 hit paper
114 papers, 4.7k citations indexed

About

Michael Lever is a scholar working on Rheumatology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Michael Lever has authored 114 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 34 papers in Clinical Biochemistry and 22 papers in Molecular Biology. Recurrent topics in Michael Lever's work include Folate and B Vitamins Research (51 papers), Metabolism and Genetic Disorders (34 papers) and Alcoholism and Thiamine Deficiency (11 papers). Michael Lever is often cited by papers focused on Folate and B Vitamins Research (51 papers), Metabolism and Genetic Disorders (34 papers) and Alcoholism and Thiamine Deficiency (11 papers). Michael Lever collaborates with scholars based in New Zealand, Canada and United States. Michael Lever's co-authors include Sandy Slow, Stephen T. Chambers, Peter M. George, Sarah L. Molyneux, Christopher J. McEntyre, Wendy Atkinson, Richard A. Robson, Peter M. George, Christopher Frampton and Jane Elmslie and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael Lever

112 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new reaction for colorimetric determination of carbohydrates

1972 759 citations Michael Lever profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lever New Zealand	34	1.8k	989	686	671	625	114	4.7k
Alfonso Pompella Italy	42	2.2k 1.2×	548 0.6×	688 1.0×	447 0.7×	169 0.3×	158	7.0k
Takeshi Nishino Japan	47	4.0k 2.2×	699 0.7×	507 0.7×	566 0.8×	590 0.9×	135	6.9k
Michael Fenech Australia	31	2.4k 1.3×	1.1k 1.1×	828 1.2×	1.1k 1.7×	137 0.2×	68	7.6k
Jennifer M. Ames United Kingdom	48	1.7k 0.9×	216 0.2×	821 1.2×	982 1.5×	2.2k 3.6×	136	8.9k
Robert B. Rucker United States	42	2.4k 1.3×	343 0.3×	490 0.7×	372 0.6×	192 0.3×	176	6.4k
Emily Shacter United States	42	3.9k 2.1×	211 0.2×	1.2k 1.8×	583 0.9×	440 0.7×	71	9.8k
Roberto Colombo Italy	29	3.4k 1.8×	243 0.2×	1.5k 2.2×	440 0.7×	639 1.0×	61	7.7k
Jeanne I. Rader United States	39	963 0.5×	1.1k 1.2×	286 0.4×	527 0.8×	115 0.2×	105	4.5k
Haïm Tapiero France	26	2.6k 1.4×	274 0.3×	517 0.8×	844 1.3×	132 0.2×	92	8.2k
Masayasu Inoue Japan	48	2.9k 1.6×	193 0.2×	1.3k 1.9×	428 0.6×	449 0.7×	268	8.6k

Countries citing papers authored by Michael Lever

Since Specialization

Citations

This map shows the geographic impact of Michael Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lever more than expected).

Fields of papers citing papers by Michael Lever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lever. The network helps show where Michael Lever may publish in the future.

Co-authorship network of co-authors of Michael Lever

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lever. A scholar is included among the top collaborators of Michael Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lever. Michael Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meredith, Megan, Sandy Slow, Michael Lever, et al.. (2017). Betaine is accumulated via transient choline dehydrogenase activation during mouse oocyte meiotic maturation. Journal of Biological Chemistry. 292(33). 13784–13794. 12 indexed citations

Lever, Michael, Christopher J. McEntyre, Peter M. George, et al.. (2014). Extreme Urinary Betaine Losses in Type 2 Diabetes Combined with Bezafibrate Treatment are Associated with Losses of Dimethylglycine and Choline but not with Increased Losses of Other Osmolytes. Cardiovascular Drugs and Therapy. 28(5). 459–468. 16 indexed citations

Lever, Michael, Peter M. George, Wendy Atkinson, et al.. (2012). The Contrasting Relationships between Betaine and Homocysteine in Two Clinical Cohorts are Associated with Plasma Lipids and Drug Treatments. PLoS ONE. 7(3). e32460–e32460. 5 indexed citations

Lever, Michael, Sandy Slow, Peter M. George, & Stephen T. Chambers. (2011). Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated. Clinical Biochemistry. 45(1-2). 154–156. 6 indexed citations

Slow, Sandy, et al.. (2009). Plasma dependent and independent accumulation of betaine in male and female rat tissues. Physiological Research. 58(3). 403–410. 86 indexed citations

Molyneux, Sarah L., Christopher M Florkowski, Peter M. George, et al.. (2008). Coenzyme Q10. Journal of the American College of Cardiology. 52(18). 1435–1441. 163 indexed citations

Lever, Michael, Wendy Atkinson, Peter Sizeland, Stephen T. Chambers, & Peter M. George. (2007). Inter- and intra-individual variations in normal urinary glycine betaine excretion. Clinical Biochemistry. 40(7). 447–453. 12 indexed citations

Slow, Sandy, W. Eugene Miller, David O. McGregor, et al.. (2004). Trigonelline is not responsible for the acute increase in plasma homocysteine following ingestion of instant coffee. European Journal of Clinical Nutrition. 58(9). 1253–1256. 10 indexed citations

Slow, Sandy, David O. McGregor, Michael Lever, et al.. (2004). Dimethylglycine supplementation does not affect plasma homocysteine concentrations in pre-dialysis chronic renal failure patients. Clinical Biochemistry. 37(11). 974–976. 11 indexed citations

10.

Lever, Michael, et al.. (2003). Short and long-term variation of plasma glycine betaine concentrations in humans. Clinical Biochemistry. 37(3). 184–190. 61 indexed citations

11.

McGregor, David O., et al.. (2002). Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney International. 61(3). 1040–1046. 67 indexed citations

12.

Lever, Michael, John W. Blunt, & Robert G. A. R. Maclagan. (2001). Some ways of looking at compensatory kosmotropes and different water environments. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 130(3). 471–486. 24 indexed citations

13.

McGregor, David O., et al.. (2001). Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney International. 59(6). 2267–2272. 82 indexed citations

14.

Chambers, Stephen T., et al.. (2001). Glycine betaine excretion is not directly linked to plasma glucose concentrations in hyperglycaemia. Diabetes Research and Clinical Practice. 52(3). 165–169. 9 indexed citations

15.

McGregor, David O., et al.. (2001). Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney International. 59(6). 2267–2267. 5 indexed citations

16.

Lever, Michael, et al.. (1999). Osmoprotective activity, urea protection, and accumulation of hydrophilic betaines in Escherichia coli and Staphylococcus aureus. Antonie van Leeuwenhoek. 75(3). 183–189. 20 indexed citations

17.

Lever, Michael, et al.. (1998). Osmoprotective properties and accumulation of betaine analogues byStaphylococcus aureus. FEMS Microbiology Letters. 160(1). 25–30. 28 indexed citations

18.

Lever, Michael, et al.. (1996). Accumulation of natural and synthetic betaines by a mammalian renal cell line. Biochemistry and Cell Biology. 74(2). 283–287. 17 indexed citations

19.

Chambers, Stephen T., et al.. (1996). Is the ability of urinary tract pathogens to accumulate glycine betaine a factor in the virulence of pathogenic strains?. Journal of Laboratory and Clinical Medicine. 128(4). 417–422. 14 indexed citations

20.

Lever, Michael, et al.. (1994). Glycine betaine and proline betaine in human blood and urine. Biochimica et Biophysica Acta (BBA) - General Subjects. 1200(3). 259–264. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact